BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography

Not Applicable

Withdrawn

Conditions: Uveitis

Interventions: Device: Ultrasonography B-scan

First Posted Date: 2014-12-08

Last Posted Date: 2023-08-15

Lead Sponsor: University of Nebraska

Registration Number: NCT02311192

The Effect of Sleeve Gastrectomy on Post-prandial Serum Bile Acids

Completed

Conditions: Obesity

First Posted Date: 2014-11-27

Last Posted Date: 2023-09-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 40

Registration Number: NCT02302677

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Phase 1

Completed

Conditions: Neovascular Macular Degeneration

Interventions: Drug: Aflibercept

First Posted Date: 2014-07-30

Last Posted Date: 2023-09-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 5

Registration Number: NCT02204683

Locations: 🇺🇸
University of Nebraska Medical Center, Truhlsen Eye Institute, Omaha, Nebraska, United States

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

Conditions: Particularly Rural/Urban Residence
Comorbid Conditions
FACT-TOI Scores
Age
Gender

First Posted Date: 2014-07-15

Last Posted Date: 2015-12-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 210

Registration Number: NCT02190864

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
Nebraska-Western Iowa (NWI) VA Health Care System, Omaha, Nebraska, United States
🇺🇸
Kansas City VA Medical Center, Kansas City, Missouri, United States

and more 5 locations

Heartland Osteoporosis Prevention Study

Phase 3

Completed

Conditions: Osteopenia

Interventions: Drug: Calcium Carbonate
Drug: Vitamin D3
Behavioral: Bone-loading exercises
Drug: Risedronate

First Posted Date: 2014-07-10

Last Posted Date: 2023-10-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 276

Registration Number: NCT02186600

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Microvascular Recovery With Ultrasound in Myocardial Infarction (MRUSMI) Post PCI Trial

Not Applicable

Completed

Conditions: STEMI
Chest Pain

Interventions: Procedure: percutaneous intervention (PCI)
Drug: Microbubbles
Procedure: Ultrasound

First Posted Date: 2014-06-23

Last Posted Date: 2023-10-31

Lead Sponsor: University of Nebraska

Target Recruit Count: 50

Registration Number: NCT02170103

Locations: 🇳🇱
VU University Medical Center, Amsterdam, Netherlands
🇧🇷
University of Sao Paulo Medical Center, Sao Paulo, Brazil

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

Phase 1

Terminated

Conditions: Anaplastic Oligoastrocytoma
Gliosarcoma
Anaplastic Oligodendroglioma
Glioblastoma
Anaplastic Astrocytoma

Interventions: Dietary Supplement: ascorbic acid
Drug: temozolomide
Other: quality-of-life assessment
Other: laboratory biomarker analysis

First Posted Date: 2014-06-20

Last Posted Date: 2023-11-24

Lead Sponsor: University of Nebraska

Target Recruit Count: 4

Registration Number: NCT02168270

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Total Shoulder Replacement Outcomes With Autologous Bone Graft as Fixator for Glenoid Anchor Peg.

Withdrawn

Conditions: Arthritis

First Posted Date: 2014-05-12

Last Posted Date: 2023-08-14

Lead Sponsor: University of Nebraska

Registration Number: NCT02136251

Bone Disease in Chronic Pancreatitis: A Complex Phenomenon

Completed

Conditions: Osteopenia
Chronic Pancreatitis
Osteoporosis

First Posted Date: 2014-04-09

Last Posted Date: 2023-09-25

Lead Sponsor: University of Nebraska

Target Recruit Count: 55

Registration Number: NCT02108509

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

Terminated

Conditions: Central Nervous System Neoplasms

First Posted Date: 2014-03-24

Last Posted Date: 2023-08-23

Lead Sponsor: University of Nebraska

Target Recruit Count: 6

Registration Number: NCT02095353

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy